Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Nanoprobe technology to throw light on disease
Investigators from Rice University’s Center for Biological and Environmental Nanotechnology (CBEN) have developed a “smart” beacon hundreds of times smaller than a human cell that is programmed to
Investigators from Rice University’s Center for Biological and Environmental Nanotechnology (CBEN) have developed a “smart” beacon hundreds of times smaller than a human cell that is programmed to
The US university is trialing a scheme in which cells can be destroyed by inserting nanotubules inside them and then applying heat. Researchers have successfully destroyed cells in
The recalled over-the-counter products come with syringes that only have a 1.6ml marking, making it difficult to accurately measure smaller doses than this, as may be prescribed for
The gene, called Arf, prevents the accumulation of certain cells, called pericytes, which nurture the growth of blood vessels in the eye during embryonic development. In normal circumstances
Results from the tests reveal that brain cell damage in primates treated with NtCell was five times less likely than in control animals affected by Huntington’s disease; this
The active ingredient of Orapred, prednisolone, is commonly used to reduce inflammation seen in numerous medical conditions including asthma, arthritis and cancer. The new formulation of Orapred, known
Abbott will now stop its co-distribution of the painkilling arthritis drug, Mobic, and the enlarged prostate drug, Flomax, at the beginning of 2006. It will continue to co-distribute
PowderMed has produced an H5N1 vaccine by cloning the H5 gene from the current circulating avian flu strain into its proprietary DNA vaccine backbone. Manufacturing and toxicology studies
The results demonstrate that testosterone introduced into the system by way of the company’s film strip can produce increased levels of the hormone in the blood, allowing for
The new drug application submitted to the FDA includes significant positive outcomes of two late stage trials, which enrolled a total of 537 patients in 28 centers across